BioSolution, a high-tech biopharmaceutical company, and Cosmax BTI, a cosmetics ODM company, have signed a memorandum of understanding (MOU) for the "development of a platform for new cosmetics materials."

Through joint development of a new cosmetic material platform, the two companies will promote the development of a next-generation functional raw material platform and product that can lead a new trend in the cosmetic market.

BioSolution is a company specializing in cell therapy established in 2000 and was listed on the KOSDAQ in 2018. It received an item license for three types of cell therapy drugs and achieved the feat of registering the first human tissue model OECD TG in 2019 in Korea.

※For more information on this article, please contact The K Beauty Science. We offer it for free of charge, and only for those who request it. Contact: office@thekbs.co.kr

키워드
#BioSolutio #Cosmax
Copyright © THE K BEAUTY SCIENCE All rights reserved. Any unauthorized copying, alteration, distribution, transmission, performance, display or other use of this material is prohibited.